HR 6062
116th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Health technology, devices, supplies
To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.
Introduced: March 3, 2020
Introduced by:
Schneider, Bradley Scott
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 4, 2020
Sponsor introductory remarks on measure. (CR H1476)
Mar 3, 2020
Referred to the House Committee on Energy and Commerce.
Mar 3, 2020
Introduced in House
Plain-English summary
This bill expands existing requirements relating to supply shortages of life-saving drugs to also apply to life-saving medical devices.
Generally, a manufacturer must (1) notify the Food and Drug Administration (FDA) of supply interruptions in certain circumstances, (2) provide for the expedited review of a new device that may mitigate the shortage, and (3) allow the FDA to authorize the importation of the device for emergency medical care.
What's happening now
Sponsor introductory remarks on measure. (CR H1476)
Committees of jurisdiction
1
Cosponsors
1